CARRIE MCCOWAN: Open Payments
NPI 1518029727 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 37 payments from 14 companies in 2025. Trend: 2023 $317 · 2024 $582 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 14 | $406 |
| ABBVIE INC. | 6 | $88 |
| Collegium Pharmaceutical, Inc. | 4 | $78 |
| Novo Nordisk Inc | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Tris Pharma Inc | 1 | $20 |
| SANOFI-AVENTIS U.S. LLC | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: HETLIOZ, FANAPT, VRAYLAR, Jornay PM, CAPLYTA, Dyanavel XR, TZIELD, Ozempic.
Industry payments across KY — which companies pay providers there.
